Radiofrequency ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
34	Neurofibromatosis	1
46	Malignant rheumatoid arthritis	1

34. Neurofibromatosis

Clinical trials : 137 / Drugs : 213 - (DrugBank : 76) / Drug target genes : 87 - Drug target pathways : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04730583 (ClinicalTrials.gov)	May 2021	12/1/2021	Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas	Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas	Cutaneous Neurofibroma	Drug: Kybella;Device: 980nm laser;Device: 755nm Alexandrite Laser;Device: Radiofrequency	Massachusetts General Hospital	Johns Hopkins University	Not yet recruiting	18 Years	85 Years	All	20	Phase 1	NULL

Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03852355 (ClinicalTrials.gov)	February 25, 2019	22/2/2019	the Effectiveness of 3rd Occipital RadiofrequencyVersus Systemic Steroid in Headache Management in R ...	the Effectiveness of 3rd Occipital RadiofrequencyVersus Systemic Steroid in Headache Management in R ...	Rheumatoid Arthritis;Headache	Drug: Radiofrequency;Drug: Steroids	Assiut University	NULL	Completed	18 Years	60 Years	All	60	N/A	Egypt